Deferred Income Tax Assets, Net of LakeShore Biopharma Co., Ltd. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
LakeShore Biopharma Co., Ltd. quarterly Deferred Income Tax Assets, Net in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Deferred Income Tax Assets, Net for the quarter ending 31 Mar 2025 was $3,893,247, a 17% increase year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Deferred Income Tax Assets, Net in CNY history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Deferred Income Tax Assets, Net for the quarter ending 31 Mar 2025 was ¥27,946,500, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)
Deferred Income Tax Assets, Net, Quarterly (CNY)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Deferred Income Tax Assets, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,893,247 +$562,142 +17% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 $3,331,105 +$3,053,796 +1101% 31 Mar 2024 20-F 15 Aug 2024 2024 FY
Q1 2023 $277,309 31 Mar 2023 20-F 26 Jul 2023 2023 FY

LakeShore Biopharma Co., Ltd. Quarterly Deferred Income Tax Assets, Net (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥27,946,500 +¥4,312,311 +18% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 ¥23,634,189 +¥21,728,608 +1140% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q1 2023 ¥1,905,581 -¥1,133,503 -37% 31 Mar 2023 20-F 15 Aug 2024 2024 FY
Q1 2022 ¥3,039,084 31 Mar 2022 20-F 26 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.